Improving therapy in metastatic uveal melanoma by understanding prior failures
Oncoscience
.
2020 Jun 1;7(5-6):40-43.
doi: 10.18632/oncoscience.510.
eCollection 2020 May.
Authors
Daniel J Olson
1
,
Jason J Luke
2
Affiliations
1
University of Chicago Comprehensive Cancer Center, Chicago, IL, USA.
2
UPMC Hillman Cancer Center, UPMC, Pittsburgh, PA, USA.
PMID:
32676517
PMCID:
PMC7343574
DOI:
10.18632/oncoscience.510
No abstract available
Keywords:
cabozantinib; immunotherapy; targeted therapy; uveal melanoma.
Grants and funding
T32 GM007019/GM/NIGMS NIH HHS/United States